Name: 15-hydroxyprostaglandin dehydrogenase [NAD+] Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

15-hydroxyprostaglandin dehydrogenase [NAD+] Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	(5Z)-5-[[4-(2-Cyclohexylethoxy)phenyl]methylidene]-1,3-thiazolidine-2,4-dione	IC50	50.9 ^[1], 51.0 ^[2]
	2-(Butane-1-sulfinyl)-4-phenyl-6-(thiophen-2-yl)thieno[2,3-b]pyridin-3-amine	IC50	2.2 ^[1]
	2-(Butane-1-sulfinyl)-4-phenyl-6-(thiophen-2-yl)thieno[2,3-b]pyridin-3-amine	Ki	0.1 ^[1]
	5-[(Z)-4-(Cyclopentylmethoxy)benzylidene]thiazolidine-2,4-dione	IC50	42.5 ^[1], 45.0 ^[2]
	CID 46836953	IC50	7.2 ^[1], 8.0 ^[2]
Rows per page: 1–5 of 100

References

This online resource may be cited as follows

MLA	"Quest Database™ 15-hydroxyprostaglandin dehydrogenase [NAD+] Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 14 Oct. 2025, https://www.aatbio.com/data-sets/15-hydroxyprostaglandin-dehydrogenase-nad-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, October 14). Quest Database™ 15-hydroxyprostaglandin dehydrogenase [NAD+] Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/15-hydroxyprostaglandin-dehydrogenase-nad-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan